Kala Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Kala Pharmaceuticals, Inc. net revenue for today is 3 266 000 $. The dynamics of Kala Pharmaceuticals, Inc. net revenue grew by 1 028 000 $ compared to the previous report. The dynamics of net income of Kala Pharmaceuticals, Inc. has changed by 700 000 $ in recent years. The financial graph of Kala Pharmaceuticals, Inc. shows the values and changes of such indicators: total assets, net income, net revenue. Kala Pharmaceuticals, Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. The value of all Kala Pharmaceuticals, Inc. assets on the graph is shown in green.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
3 266 000 $
+135.64 % ↑
-30 412 000 $
-
31/12/2020
2 238 000 $
-
-31 112 000 $
-
30/09/2020
2 220 000 $
-
-27 948 000 $
-
30/06/2020
833 000 $
-
-23 312 000 $
-
31/03/2019
1 386 000 $
-
-25 388 000 $
-
31/12/2018
0 $
-
-25 219 000 $
-
30/09/2018
0 $
-
-15 603 000 $
-
30/06/2018
0 $
-
-14 620 000 $
-
Show:
to
Kala Pharmaceuticals, Inc. financial report charts
Dates of Kala Pharmaceuticals, Inc. finance reports: 30/06/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Kala Pharmaceuticals, Inc. for today is 31/03/2021. Gross profit Kala Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Kala Pharmaceuticals, Inc. is 2 511 000 $
Kala Pharmaceuticals, Inc. quarterly report dates
Cost of revenue Kala Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Kala Pharmaceuticals, Inc. is 755 000 $ Total revenue Kala Pharmaceuticals, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Kala Pharmaceuticals, Inc. is 3 266 000 $ Operating income Kala Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Kala Pharmaceuticals, Inc. is -28 314 000 $
Net income Kala Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Kala Pharmaceuticals, Inc. is -30 412 000 $ Current assets Kala Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Kala Pharmaceuticals, Inc. is 179 065 000 $ Total assets Kala Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Kala Pharmaceuticals, Inc. is 229 827 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 511 000 $
1 879 000 $
1 519 000 $
74 000 $
1 145 000 $
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
755 000 $
359 000 $
701 000 $
759 000 $
241 000 $
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
3 266 000 $
2 238 000 $
2 220 000 $
833 000 $
1 386 000 $
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
1 386 000 $
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-28 314 000 $
-27 984 000 $
-25 842 000 $
-21 280 000 $
-24 050 000 $
-23 568 000 $
-15 496 000 $
-14 519 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-30 412 000 $
-31 112 000 $
-27 948 000 $
-23 312 000 $
-25 388 000 $
-25 219 000 $
-15 603 000 $
-14 620 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
3 126 000 $
3 397 000 $
3 468 000 $
6 053 000 $
6 959 000 $
9 239 000 $
7 027 000 $
7 368 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
31 580 000 $
30 222 000 $
28 062 000 $
22 113 000 $
25 436 000 $
23 568 000 $
15 496 000 $
14 519 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
179 065 000 $
171 379 000 $
178 156 000 $
197 024 000 $
150 449 000 $
177 028 000 $
80 455 000 $
91 936 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
229 827 000 $
221 606 000 $
225 096 000 $
245 510 000 $
197 016 000 $
220 966 000 $
84 075 000 $
95 590 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
127 970 000 $
77 264 000 $
45 526 000 $
128 023 000 $
138 944 000 $
170 898 000 $
74 910 000 $
91 205 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
14 602 000 $
17 010 000 $
12 685 000 $
9 397 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
114 649 000 $
115 988 000 $
29 141 000 $
27 497 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
58.19 %
52.49 %
34.66 %
28.77 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
109 792 000 $
99 995 000 $
106 030 000 $
128 943 000 $
82 367 000 $
104 978 000 $
54 934 000 $
68 093 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-31 170 000 $
-15 989 000 $
-16 217 000 $
-9 205 000 $
Last revenue report of Kala Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in Kala Pharmaceuticals, Inc. was 3 266 000 US dollar and changed by +135.64% since last year. Net income in Kala Pharmaceuticals, Inc. was -30 412 000 $ in last quartal, net income changes to 0%.
Current cash Kala Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Kala Pharmaceuticals, Inc. is 127 970 000 $
Kala Pharmaceuticals, Inc. stocks data
KALA stock price
Kala Pharmaceuticals, Inc. stock price today, KALA stock quote.
